Showing results (11-20 of 123) with videos related to
Sort By:
Pageof 13
Anticancer Research|July 5, 2022
SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental StudyTaihei Kajiyama, Satoshi Serada, Minoru Fujimoto, et al.Scientific Reports|February 27, 2020
Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosisMinoru Fujimoto, Tomoshige Matsumoto, Satoshi Serada, et al.Plos One|June 2, 2020
Correlation of increased serum leucine-rich α2-glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A retrospective studyTakaaki Ishida, Takuya Kotani, Satoshi Serada, et al.Biochemical and Biophysical Research Communications|March 19, 2018
Leucine rich α-2 glycoprotein is a potential urinary biomarker for renal tubular injuryHyun Lee, Minoru Fujimoto, Tomoharu Ohkawara, et al.Expert Opinion on Therapeutic Targets|February 1, 2014
Annexin A4 is a promising therapeutic target for the treatment of platinum-resistant cancersShinya Matsuzaki, Satoshi Serada, Akiko Morimoto, et al.Plos One|October 8, 2013
Karyopherin alpha2 is essential for rRNA transcription and protein synthesis in proliferative keratinocytesNoriko Umegaki-Arao, Katsuto Tamai, Keisuke Nimura, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 2, 2021
The Skin-Liver Axis Modulates the Psoriasiform Phenotype and Involves Leucine-Rich α-2 GlycoproteinHideki Nakajima, Kimiko Nakajima, Mikiro Takaishi, et al.Proceedings of the National Academy of Sciences of the United States of America|May 16, 2013
CD134 is a cellular receptor specific for human herpesvirus-6B entryHuamin Tang, Satoshi Serada, Akiko Kawabata, et al.Journal of Virology|October 25, 2013
Varicella-zoster virus ORF49 functions in the efficient production of progeny virus through its interaction with essential tegument protein ORF44Tomohiko Sadaoka, Satoshi Serada, Junko Kato, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|December 8, 2021
Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinomaKie Nakatani, Satoshi Serada, Minoru Fujimoto, et al.Pageof 13